Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

As of 2024-11-13, Thermo Fisher Scientific Inc's intrinsic value as calculated by the Discounted Earnings model is $670.00.

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Daymon Loeb of Ravenstone Capital Management in Toronto, also owns Canadian Pacific Kansas City, Canadian National Railway ...

Thermo Fisher Scientific Inc. has notified the state that it plans to lay off employees at two Massachusetts sites and close a third entirely.

the company highlighted applications of the technology in the context of neurodegenerative disease, cancer, and metabolic ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Thermo Fisher Scientific Inc. closed $67.09 below its 52-week high ($627.88), which the company achieved on September 10th.

Thermo Fisher Scientific (NYSE:TMO) is closing a facility as part of a shift in operations across Massachusetts.

The US$656 analyst price target for TMO is 18% less than our estimate of fair value Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Thermo Fisher ...

(Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a co-marketing and sales agreement with Thermo Fisher Scientific, the world ...